John R Wunderlich Selected Research

gp100 Melanoma Antigen

10/2009	Impact of a recombinant fowlpox vaccine on the efficacy of adoptive cell therapy with tumor infiltrating lymphocytes in a patient with metastatic melanoma.
8/2003	Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John R Wunderlich Research Topics

Disease

43	Neoplasms (Cancer) 01/2019 - 05/2002
38	Melanoma (Melanoma, Malignant) 01/2017 - 05/2002
8	Neoplasm Metastasis (Metastasis) 11/2018 - 05/2002
3	Lymphopenia (Lymphocytopenia) 01/2017 - 05/2002
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2015 - 09/2013
3	Testicular Neoplasms (Testicular Cancer) 05/2014 - 01/2006
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 05/2015
2	Ovarian Neoplasms (Ovarian Cancer) 11/2018 - 10/2006
2	Disease Progression 01/2017 - 12/2010
2	Uveal melanoma 01/2017 - 01/2016
2	Neutropenia 01/2017 - 04/2005
2	Thrombocytopenia (Thrombopenia) 01/2017 - 04/2005
2	Sarcoma (Soft Tissue Sarcoma) 03/2015 - 03/2011
2	Fowlpox 10/2009 - 08/2003
1	Carcinoma (Carcinomatosis) 01/2019
1	Infections 01/2017
1	Cholangiocarcinoma 05/2014
1	Adenocarcinoma 01/2014
1	Stomach Neoplasms (Stomach Cancer) 01/2014
1	Carcinogenesis 10/2009
1	Uveitis 07/2009
1	Hearing Loss (Hearing Impairment) 07/2009
1	Exanthema (Rash) 10/2006
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 04/2005
1	Kidney Neoplasms (Kidney Cancer) 05/2002

Drug/Important Bio-Agent (IBA)

15	Interleukin-2 (IL2)IBA 02/2015 - 05/2002
14	AntigensIBA 03/2015 - 08/2003
8	Neoplasm Antigens (Tumor Antigens)IBA 04/2016 - 05/2002
7	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2018 - 10/2006
6	EpitopesIBA 11/2018 - 05/2002
5	Differentiation AntigensIBA 01/2016 - 05/2002
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2008
4	HLA-A*02:01 antigenIBA 03/2015 - 05/2002
4	VaccinesIBA 10/2009 - 08/2003
4	Peptides (Polypeptides)IBA 11/2006 - 05/2002
3	InterleukinsIBA 12/2010 - 08/2003
3	CytokinesIBA 12/2008 - 05/2002
2	HLA Antigens (Human Leukocyte Antigens)IBA 11/2018 - 12/2015
2	Immunoglobulins (Immunoglobulin)IBA 08/2017 - 05/2014
2	SuspensionsIBA 10/2012 - 12/2008
2	gp100 Melanoma AntigenIBA 10/2009 - 08/2003
2	MART-1 AntigenIBA 08/2009 - 05/2002
2	fludarabineIBA 04/2005 - 05/2002
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2005 - 05/2002
2	Melanoma-Specific AntigensIBA 09/2003 - 05/2002
1	Mutant Proteins (Protein, Mutant)IBA 01/2019
1	HLA-DRB3 Chains (HLA DRB3)IBA 11/2018
1	ElementsIBA 11/2018
1	Carrier Proteins (Binding Protein)IBA 08/2017
1	HLA-DRB1 Chains (HLA DRB1)IBA 08/2017
1	VemurafenibIBA 01/2017
1	Melanins (Melanin)IBA 01/2016
1	PlatinumIBA 05/2015
1	AutoantigensIBA 02/2015
1	Monophenol Monooxygenase (Tyrosinase)IBA 05/2014
1	Proteins (Proteins, Gene)FDA Link 05/2014
1	Member 9 Tumor Necrosis Factor Receptor SuperfamilyIBA 05/2014
1	MucinsIBA 05/2014
1	HLA-C Antigens (HLA-C)IBA 01/2014
1	HLA-B Antigens (HLA-B)IBA 01/2014
1	RNA (Ribonucleic Acid)IBA 09/2013
1	Interferon-gamma (Interferon, gamma)IBA 06/2013
1	Programmed Cell Death 1 ReceptorIBA 11/2010
1	InterferonsIBA 11/2010
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2009
1	Phosphotransferases (Kinase)IBA 10/2009
1	Lapatinib (GW572016)FDA Link 10/2009
1	Small Interfering RNA (siRNA)IBA 10/2009
1	Tyrosine (L-Tyrosine)FDA Link 10/2009
1	SteroidsIBA 07/2009
1	AgarIBA 05/2009
1	Matrix Metalloproteinases (MMPs)IBA 05/2009
1	Cancer VaccinesIBA 11/2006
1	IgG Receptors (Fc gamma RI)IBA 10/2006
1	Folic Acid (Vitamin M)FDA LinkGeneric 10/2006
1	ChemokinesIBA 10/2006
1	6-sulfo sialyl Lewis XIBA 10/2006
1	Decitabine FDA Link 01/2006
1	Glycoproteins (Glycoprotein)IBA 09/2003
1	beta 2-Microglobulin (beta 2 Microglobulin)IBA 09/2003
1	Amino Acids FDA Link 08/2003
1	flt3 ligand protein (flt3 ligand)IBA 05/2002

Therapy/Procedure

29	Therapeutics 01/2019 - 05/2002
14	Immunotherapy 01/2019 - 05/2002
11	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2018 - 10/2008
11	Drug Therapy (Chemotherapy) 01/2017 - 05/2002
2	Aftercare (After-Treatment) 01/2019 - 05/2015
1	Chemoradiotherapy 05/2015
1	Metastasectomy 12/2010
1	Biological Therapy 10/2006
1	Intravenous Administration 09/2003